Invion Limited

Research Invion Limited (7C8) on Bullrun: market cap EUR 2.18M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker7C8
• ExchangeF
• CountryAustralia
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 2.18M
• Financial periodFY2025
• Net income-EUR 8.81M
• Free cash flow-EUR 2.97M

Valuation Snapshot

latest market cap is EUR 2.18M.

About Invion Limited

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus.

Frequently asked questions

What is Invion Limited's market cap?

Invion Limited's market capitalization is EUR 2.18M.

What does Invion Limited do?

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.